You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

LIVOSTIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Livostin, and what generic alternatives are available?

Livostin is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in LIVOSTIN is levocabastine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the levocabastine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LIVOSTIN?
  • What are the global sales for LIVOSTIN?
  • What is Average Wholesale Price for LIVOSTIN?
Summary for LIVOSTIN
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 47
Patent Applications: 622
DailyMed Link:LIVOSTIN at DailyMed
Drug patent expirations by year for LIVOSTIN

US Patents and Regulatory Information for LIVOSTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis LIVOSTIN levocabastine hydrochloride SUSPENSION/DROPS;OPHTHALMIC 020219-001 Nov 10, 1993 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for LIVOSTIN

See the table below for patents covering LIVOSTIN around the world.

Country Patent Number Title Estimated Expiration
Japan S6412270 ⤷  Sign Up
Japan S6034759 APPARATUS FOR FILM TREATING OF METAL OR NON-METAL WORK ⤷  Sign Up
Germany 3313533 ⤷  Sign Up
Latvia 5041 1-cikloheksil-4-aril-4-piperidinkarbonskabju atvasinajumu vai to skabju-aditivo salu vai to stereokimisko izomeru iegusanas metode (tas varianti) ⤷  Sign Up
South Korea 830005139 ⤷  Sign Up
Canada 1187080 DERIVES DE L'ACIDE 1-(CYCLOHEXYL)-4-ARYL-4- PIPERIDINE-CARBOXYLIQUE (1-(CYCLOHEXYL)-4-ARYL-4-PIPERIDINE-CARBOXYLIC ACID DERIVATIVES) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for LIVOSTIN

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0034415 93C0014 Belgium ⤷  Sign Up PRODUCT NAME: LEVOCABASTINE HYDROCHLORIDE; NAT. REG.: 2S 400 F 11 19910604; FIRST REG.: DK 8252 19910111
0034415 SPC/GB95/006 United Kingdom ⤷  Sign Up SPC/GB95/006, EXPIRES: 20060110
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.